Skip to main content
Log in

Beta-adrenergic receptors in DMBA-induced rat mammary tumors: Correlation with progesterone receptor and tumor growth

  • Report
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Summary

In order to gain further knowledge about the potential role of catecholamines in mammary carcinoma, we have used the potent β-adrenergic antagonist cyanopindolol (CYP) as iodinated ligand to characterize β-adrenergic receptors in membranes prepared from mammary tumors induced by dimethylbenz(a)anthraene (DMBA) administration in the rat. The binding of [125I]CYP to membrane preparations of DMBA-induced rat mammary tumors is rapid at room temperature, reaching half maximal specific binding at 30 min of incubation. Scatchard analysis of the data indicates that [125I]CYP binds to a single class of high affinity sites (114 ± 2.1 fmoles/mg protein) at an apparent KD value of 38.0 ± 0.3 pM. The order of potency of a series of agonists to compete for [125I]CYP binding is consistent with interaction with a β2-subtype receptor: zinterol > (−)isoproterenol > (−)epinephrine» (−)norepinephrine. In addition, the potency of a series of specific β1, and β2 synthetic compounds to displace [125I]CYP in mammary tumors is similar to their potency in typical β2-adrenergic tissues. The binding of [125I]CYP to DMBA-induced rat mammary tumors shows a marked stereoselectivity, the (−)isomers of isoproterenol and propranolol being 150 and 80 times more potent, respectively, than their respective enantiomers. The autoradiographic localization of [125I]CYP performed on frozen sections revealed the presence of specific β-adrenergic receptors in all the malignant cells. Spontaneous mammary tumors of aging (18–22 months) female rats have high levels of β-adrenergic receptors. Castration decreased the concentration of [125I]CYP binding sites in DMBA-induced mammary tumors. A close correlation was observed between progressing, static, and regressing tumors after ovariectomy and β-adrenergic receptor concentration. The presence of β-adrenergic receptors in mammary tumors as well as the modulation of their level by ovarian hormones provides a mechanism for catecholaminergic influence in mammary cancer tissue.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Williams LT, Lefkowitz RJ: Regulation of rabbit myometrial alpha-adrenergic receptors by estrogen and progesterone. J Clin Invest 60: 815–818, 1977

    PubMed  Google Scholar 

  2. Krall JF, Mori H, Tuck ML, LeShon SL, Korenman SG: Demonstration of adrenergic catecholamines receptors in rat myometrium and their regulation by sex steroid hormones. Life Sci 23: 1073–1081, 1978

    Article  PubMed  Google Scholar 

  3. Jordan AW: Changes in ovarian β-adrenergic receptors during the estrous cycle of the rat. Biol Reprod 24: 245–248, 1981

    PubMed  Google Scholar 

  4. Adashi EY, Hsueh AJW: Stimulation of β2-adrenergic receptor responsiveness by follicle-stimulating hormone in rat granulosa cellsin vitro andin vivo. Endocrinology 108: 2170–2178, 1981

    PubMed  Google Scholar 

  5. Aguado LI, Petrovic SL, Ojeda SR: Ovarian β-adrenergic receptors during the onset of puberty: characterization, distribution and coupling to steroidogenic responses. Endocrinology 110: 1124–1132, 1982

    PubMed  Google Scholar 

  6. Poyet P, Labrie F: Characterization of β-adrenergic receptors in dispersed rat Leydig cells. J Androl 8: 7–13, 1987

    PubMed  Google Scholar 

  7. Poyet P, Labrie F: Characteristics of the β-adrenergic receptors in the rat ventral prostate using [125I]cyanopindolol. Mol Cell Endocrinol 48: 59–67, 1986

    Article  PubMed  Google Scholar 

  8. Wagner HR, Crutcher KA, Davis JN: Chronic estrogen treatment decreases β-adrenergic responses in rat cerebral cortex. Brain Res 171: 147–151, 1979

    Article  PubMed  Google Scholar 

  9. Vacas MI, Lowenstein PR, Cardinali DP: Testosterone decreases β-adreno-receptors in rat pineal gland and brain. J Neural Transm 53: 49–57, 1982

    Article  PubMed  Google Scholar 

  10. Petrovic SL, Stanic MA, Haugland RP, Dowben RM: Increased β-adrenergic complement in androgen-induced mouse kidney hypertrophy. Biochim Biophys Acta 676: 329–337, 1981

    PubMed  Google Scholar 

  11. Colucci WS, Gimbrone Jr JA, Alexander RW: Estrogens, sympathectomy and catecholamines regulate the vascular alpha-adrenergic receptor. Clin Res 28: 162a (abstract), 1980

    Google Scholar 

  12. Roberts JM, Goldfien RD, Tsuschiya AM, Goldfien A, Insel PA: Estrogen treatment decreases alpha-adrenergic binding sites on rabbit platelets. Endocrinology 104: 722–728, 1979

    PubMed  Google Scholar 

  13. Elliot JM, Peters JR, Grahame-Smith DG: Oestrogen and progesterone change the binding characteristic of alphaadrenergic and serotonin receptors on rabbit platelets. Eur J Pharmacol 66: 21–20, 1980

    Article  PubMed  Google Scholar 

  14. Loizzi RF, De Pont JH, Bonting SL: Inhibition by cyclic AMP of lactose production in lactating guinea pig mammary gland slices. Biochim Biophys Acta 392: 20–22, 1975

    PubMed  Google Scholar 

  15. Plucinski TM, Baldwin RL: Effects of hormones on mammary adenosine 3′,5′-monophosphate levels and metabolism in normal and adrenalectomized lactating rats. Endocrinology 111: 2062–2065, 1982

    PubMed  Google Scholar 

  16. Bar HP: Epinephrine- and prostaglandin-sensitive adenylate cyclase in mammary gland. Biochim Biophys Acta 321: 397–406, 1980

    Google Scholar 

  17. Sapag-Hagar M, Greenbaum AL: Adenose 3′,5′-monophosphate and hormone interrelationships in the mammary gland of the rat during pregnancy and lactation. Eur J Biochem 47: 303–312, 1974

    Article  PubMed  Google Scholar 

  18. Sapag-Hagar M, Greenbaum AL: Changes in the activities of adenylate cyclase and cAMP phosphodiesterase and the level of 3′,5′-cyclic adenosine monophosphate in rat mammary gland during pregnancy and lactation. Biochem Biophys Res Commun 58: 982–988, 1973

    Article  Google Scholar 

  19. Bodwin YS, Hirayama PH, Regs YA, Cho-Chung YS: Regression of hormone-dependent mammary tumors in Sprague-Dawley rats as a result of tamoxifen or pharmacological doses of 17β-estradiol: cyclic adenosine 3′,5′-monophosphate-mediated events. J Natl Cancer Inst 66: 321–326, 1981

    PubMed  Google Scholar 

  20. Foecking MK, Abou-Issa H, Webb TE, Minton JP: Concurrent changes in growth-related biochemical parameters during regression of hormone-dependent rat mammary tumors. J Natl Cancer Inst 71: 773–778, 1983

    PubMed  Google Scholar 

  21. Ip C, Dao TL: Regulation of cyclic adenosine 3′,5′-monophosphate in relation to growth of dimethylbenz(a)anthracene-induced mammary tumors in rats. Cancer Lett 8: 227–233, 1980

    Article  PubMed  Google Scholar 

  22. Lee C: Levels of cyclic nucleotides in autotransplanted 7,12-dimethyl-benz(a)anthracene-induced rat mammary tumors during their growth and regression. J Natl Cancer Inst 65: 1029–1032, 1980

    PubMed  Google Scholar 

  23. Cho-Chung YS:In vivo inhibition of tumor growth by cyclic adenosine 3′,5′-monophosphate derivatives. Cancer Res 34: 3492–3496, 1974

    PubMed  Google Scholar 

  24. Cho-Chung YS, Clair T, Shepheard C, Berghoffer B: Arrest of hormone-dependent mammary cancer growthin vivo andin vitro by cholera toxin. Cancer Res 43: 1473–1476, 1983

    PubMed  Google Scholar 

  25. Klein DM, Loizzi RF: Enhancement of R333OAC rat mammary tumor growth and cellular differentiation by dibutyryl cyclic adenosine monophosphate. J Natl Cancer Inst 58: 813–818, 1977

    PubMed  Google Scholar 

  26. Lavandero S, Donoso E, Sapag-Hagar M: β-adrenergic receptors in rat mammary gland. Biochem Pharmacol 34: 2034–2036, 1985

    Article  PubMed  Google Scholar 

  27. Asselin J, Kelly PA, Caron MG, Labrie F: Control of hormone receptor levels and growth of 7,12-dimethylbenz (a)anthracene-induced mammary tumors by estrogens, progesterone and prolactin. Endocrinology 101: 666–671, 1977

    PubMed  Google Scholar 

  28. Meites J: Changes in neuroendocrine control of anterior pituitary function during aging. Neuroendocrinology 34: 151–156, 1982

    PubMed  Google Scholar 

  29. Marchetti B, Cioni M: Opposite changes of pituitary and ovarian receptors for LHRH in ageing rats: further evidence for a direct neural control of ovarian LHRH receptor activity. Neuroendocrinology 48: 242–251, 1988

    PubMed  Google Scholar 

  30. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin Phenol reagent. J Biol Chem 193: 265–275, 1951

    PubMed  Google Scholar 

  31. Asselin J, Labrie F, Kelly PA, Philibert D, Raynaud JP: Characteristics of binding to estrogen, androgen, progestin, and glucocorticoid receptors in 7,12-dimenthylbenz(a)anthracene-induced mammary tumors and their hormonal control. Steroids 27: 395–404, 1976

    Article  PubMed  Google Scholar 

  32. Dubé D, Poyet P, Pelletier G, Labrie F: Radioautographic localization of β-adrenergic receptors in the rat ventral prostate. J Androl 7: 169–174, 1986

    PubMed  Google Scholar 

  33. Rodbard D: Apparent positive cooperative effect in cyclic AMP and corticosterone production by related adrenal cells in response to ACTH analogs. Endocrinology 94: 1427–1437, 1974

    PubMed  Google Scholar 

  34. Rodbard D, Lewald JE: Computer analysis of radioligand assay and radioimmunoassay data. In: Diczfalusy E (ed) Second Karolinska Symposium on Research Methods in Reproductive Endocrinology, Copenhagen. Bogtrykleriet Forum, 1970, pp 79–103

    Google Scholar 

  35. Cheng Y, Prusoff WH: Relationship between the inhibition constant (Ki) and the concentration of inhibitor which cause 50 percent inhibition (IC50) of an enzymatic reaction. Biochem Pharmacol 22: 3099–3108, 1973

    Article  PubMed  Google Scholar 

  36. Scatchard G: The attractions of problems for small molecules and ions. Ann NY Acad Sci 51: 660–669, 1949

    Google Scholar 

  37. Kramer CY: Extension of multiple-range test to group means with unique numbers of replications. Biometrics 12: 307–310, 1956

    Google Scholar 

  38. Lands AM, Luduena FP, Buzzo HJ: Differentiation of receptors responsive to isoproterenol. Life Sci 6: 2241–2249, 1967

    Article  PubMed  Google Scholar 

  39. Lands AM, Arnold A, McAuliff JP, Luduena FP, Grown TG: Differentiation of receptor systems activated by sympathomimetic amines. Nature 214: 597–598, 1967

    PubMed  Google Scholar 

  40. Dolphin A, Hamont M, Bockaert J: The resolution of dopamine and β1-and β2-adrenergic sensitive adenylate cyclase activities in homogenates of a cerebellum hippocampus and cerebral cortex. Brain Res 179: 305–317, 1979

    Article  PubMed  Google Scholar 

  41. Lacombe ML, Rene E, Guellaen G, Hanoune J: Transformation of the β2-adrenoreceptor in normal rat liver into a β1 type in Zajdela hepatoma. Nature 262: 70–73, 1976

    Article  PubMed  Google Scholar 

  42. Dunlop D, Shanks RG: Selective blockade of adrenoreceptive beta-receptors in the heart. Brit J Pharmacol 32: 201–218, 1968

    PubMed  Google Scholar 

  43. Welsch CW, Nagasawa H: Prolactin and murine mammary tumorigenesis: a review. Cancer Res 37: 951–963, 1977

    PubMed  Google Scholar 

  44. Huggins C, Briziarelli G, Sutton H: Rapid induction of mammary carcinoma in the rat and the influence of hormones on the tumors. J Exp Med 109: 25–42, 1959

    Article  PubMed  Google Scholar 

  45. Russo IH, Russo J: Developmental stage of the rat mammary gland as determinants of its susceptibility to 7,12-dimethylbenz(a)anthracene. J Natl Cancer Inst 61: 1439–1449, 1978

    PubMed  Google Scholar 

  46. McCarty R: Sympathetic-adrenal medullary and cardiovascular responses to acute cold stress in adult and aged rats. J Autonom Nerv Syst 12: 15–22, 1985

    Article  Google Scholar 

  47. Sapolsky RM, Donnely T: Vulnerability to stresss-induced tumor growth increases with age in rats: role of glucocorticoids. Endocrinology 117: 662–665, 1985

    PubMed  Google Scholar 

  48. Marchetti B, Spinola PG: Hormonal regulation of β-adrenergic receptor levels in rat normal mammary gland and mammary tumors induced by dimethylbenz(a)anthracene-(DMBA)-induced mammary tumor and the correlation with tumor growth (abst). Proc. of the 69th Endocrine Society Meeting, Indianapolis, no. 947, 1987, p 257

    Google Scholar 

  49. Marchetti B, Plante M, Poulin R, Labrie F: Castration levels of plasma testosterone have potent stimulatory effects on androgen-sensitive parameters in the rat prostate. J Steroid Biochem 31: 411–419, 1988

    Article  PubMed  Google Scholar 

  50. Poyet G, Gagné B, Labrie F: Characteristics of the β-adrenergic stimulation of adenylate cyclase activity in rat ventral prostate and its modulation by androgens. Prostate 9: 237–245, 1986

    PubMed  Google Scholar 

  51. Marchetti B, Labrie F: Characteristics of Flutamide action on prostatic and testicular functions in the rat. J Steroid Biochem 29: 691–698, 1988

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Marchetti, B., Spinola, P.G., Plante, M. et al. Beta-adrenergic receptors in DMBA-induced rat mammary tumors: Correlation with progesterone receptor and tumor growth. Breast Cancer Res Tr 13, 251–263 (1989). https://doi.org/10.1007/BF02106575

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02106575

Key words

Navigation